Filing Details
- Accession Number:
- 0001013606-15-000054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-22 13:00:35
- Reporting Period:
- 2015-05-20
- Filing Date:
- 2015-05-22
- Accepted Time:
- 2015-05-22 13:00:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1013606 | Endologix Inc | ELGX | Surgical & Medical Instruments & Apparatus (3841) | 680328265 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204144 | D Gregory Waller | 10752 Rogue River Bend Tustin CA 92782 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-20 | 15,853 | $8.26 | 37,742 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-20 | 15,853 | $16.70 | 21,843 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase | Disposition | 2015-05-20 | 15,853 | $16.70 | 15,853 | $8.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-05-25 | 2021-05-25 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at price ranging from $16.60 to 16.76. The Reporting Person undertakes to provide Endologix, Inc., any security holder of Endologix, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each price within the ranges set forth in this Form 4.
Billionaire Hedge Funds
